AACR 2025: MaaT Pharma, the gut microbiome, and immuno-oncology Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.

NEWS: Lyon, France-based late-stage clinical #biotech #MaaTPharma has presented new #preclinicaldata for MaaT034 at the #AmericanAssociationforCancerResearch annual meeting 2025 in Chicago, US – with compelling anti-tumour efficacy results.

pharmaphorum.com/news/aacr-20...